Hetzel Guenter, Moeller Olaf, Evers Stefan, Erfurth Andreas, Ponath Gerald, Arolt Volker, Rothermundt Matthias
Department of Psychiatry, University of Muenster, Albert-Schweitzer-Str. 11, 48129 Muenster, Germany.
Psychopharmacology (Berl). 2005 Mar;178(2-3):161-6. doi: 10.1007/s00213-004-1999-z. Epub 2004 Aug 14.
S100B is an astrocytic, calcium-binding protein which in nanomolar concentrations has neuroprotective and regenerating effects on neurons and glial cells. Increased levels have been shown to be positively correlated with therapeutic response in major depression. Event-related potentials (ERP) have been reported to be impaired in depressed patients.
The aim of our study was to assess the relationship between S100B and visually evoked ERP in depression.
ERP and S100B serum concentration were studied in 18 patients with major depression, before and after 4 weeks of antidepressant treatment.
The S100B concentration in patients was increased at intake and after 4 weeks of treatment compared to healthy controls. Initially increased P3-latency normalized and P2-latency significantly decreased after 4 weeks of treatment, although only in patients with clearly elevated initial S100B levels (mean plus 2 SD of the healthy controls).
The neuroregenerative activity of moderately increased S100B levels in major depression might be a factor contributing to a decrease of prolonged ERP parameters in major depression during antidepressant treatment.
S100B是一种星形细胞钙结合蛋白,其纳摩尔浓度对神经元和神经胶质细胞具有神经保护和再生作用。研究表明,其水平升高与重度抑郁症的治疗反应呈正相关。据报道,抑郁症患者的事件相关电位(ERP)受损。
本研究旨在评估抑郁症患者中S100B与视觉诱发电位ERP之间的关系。
对18例重度抑郁症患者在抗抑郁治疗4周前后进行ERP和血清S100B浓度研究。
与健康对照相比,患者的S100B浓度在入组时和治疗4周后均升高。治疗4周后,最初升高的P3潜伏期恢复正常,P2潜伏期显著缩短,不过仅在初始S100B水平明显升高的患者中(健康对照均值加2个标准差)。
重度抑郁症中S100B水平适度升高的神经再生活性可能是抗抑郁治疗期间重度抑郁症患者ERP参数延长时间缩短的一个促成因素。